Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future

D Akhoundova, MA Rubin - Cancer Cell, 2022 - cell.com
Next-generation DNA sequencing technology has dramatically advanced clinical oncology
through the identification of therapeutic targets and molecular biomarkers, leading to the …

Pharmacological targeting of the cancer epigenome

NW Mabe, JA Perry, CF Malone, K Stegmaier - Nature Cancer, 2024 - nature.com
Epigenetic dysregulation is increasingly appreciated as a hallmark of cancer, including
disease initiation, maintenance and therapy resistance. As a result, there have been …

The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

C Sampson, Q Wang, W Otkur, H Zhao… - Clinical and …, 2023 - Wiley Online Library
Ubiquitination is one of the most important post‐translational modifications which plays a
significant role in conserving the homeostasis of cellular proteins. In the ubiquitination …

Synthetic E2-Ub-nucleosome conjugates for studying nucleosome ubiquitination

H Ai, Z Tong, Z Deng, J Tian, L Zhang, M Sun, Y Du… - Chem, 2023 - cell.com
Summary E2-ubiquitin (Ub) conjugates are useful chemical biology tools for studying the E3
mechanisms, but so far, the reported systems have involved either no substrates or only …

E3 ligases meet their match: fragment-based approaches to discover new E3 ligands and to unravel E3 biology

IN Michaelides, GW Collie - Journal of medicinal chemistry, 2023 - ACS Publications
Ubiquitination is a key post-translational modification of proteins, affecting the regulation of
multiple cellular processes. Cells are equipped with over 600 ubiquitin orchestrators, called …

Human serum albumin based nanodrug delivery systems: recent advances and future perspective

C Li, D Zhang, Y Pan, B Chen - Polymers, 2023 - mdpi.com
With the success of several clinical trials of products based on human serum albumin (HSA)
and the rapid development of nanotechnology, HSA-based nanodrug delivery systems …

Polycomb-dependent histone H2A ubiquitination links developmental disorders with cancer

S Tamburri, E Conway, D Pasini - Trends in Genetics, 2022 - cell.com
Cell identity is tightly controlled by specific transcriptional programs which require post-
translational modifications of histones. These histone modifications allow the establishment …

Targeted degradation of PRC1 components, BMI1 and RING1B, via a novel protein complex degrader strategy

KS Park, L Qin, M Kabir, K Luo, B Dale… - Advanced …, 2023 - Wiley Online Library
Abstract Polycomb repressive complex 1 (PRC1) is an essential epigenetic regulator that
mainly controls histone H2A Lys119 mono‐ubiquitination (H2AK119ub). B cell‐specific …

Super-enhancers, phase-separated condensates, and 3D genome organization in cancer

SC Tang, U Vijayakumar, Y Zhang, MJ Fullwood - Cancers, 2022 - mdpi.com
Simple Summary Gene expression is primarily controlled at the level of transcription, largely
due to binding of transcription factors to specific sites on DNA, namely super-enhancers and …

Diverse modes of regulating methyltransferase activity by histone ubiquitination

JK Fields, CW Hicks, C Wolberger - Current Opinion in Structural Biology, 2023 - Elsevier
Post-translational modification of histones plays a central role in regulating transcription.
Methylation of histone H3 at lysines 4 (H3K4) and 79 (H3K79) play roles in activating …